1. Human A beta-amyloid and amyloid precursor protein accumulates in rat brain cells after cultured human leptomeningeal fibroblast implants
- Author
-
Lorraine A. DeGiorgio, Jerald J. Bernstein, John P. Blass, and Laura Manuelidis
- Subjects
Pathology ,medicine.medical_specialty ,Ependymal Cell ,Amyloid ,Cell Transplantation ,Immunoblotting ,Transplantation, Heterologous ,Hippocampal formation ,Amyloid beta-Protein Precursor ,Parenchyma ,medicine ,Neuropil ,Amyloid precursor protein ,Animals ,Humans ,Tissue Distribution ,Fibroblast ,Molecular Biology ,Amyloid beta-Peptides ,Birefringence ,biology ,General Neuroscience ,Brain ,Congo Red ,Fibroblasts ,Rats ,Transplantation ,medicine.anatomical_structure ,biology.protein ,Pia Mater ,Neurology (clinical) ,Arachnoid ,Developmental Biology - Abstract
Cultured human leptomeningeal fibroblasts grafted into rat frontal cortex were localized to the implant pocket and to adjacent host leptomeninges. Immunohistochemical studies using a panel of human-specific and domain-specific APP antibodies revealed that all grafted cells expressed both APP and A β in situ. Remarkably, these antibodies also labeled rat pial and ependymal cells as well as reactive astrocytes adjacent to vessels. In addition, apical projections and cell bodies of many cortical pyramidal neurons contained human-specific APP immunoreactive material. Groups of subcortical neurons, particularly those of the amygdala, hippocampal formation and suprachiasmatic nuclei, were similarly labeled. The presence of human APP in host brains was confirmed by immunoblotting. Birefringent Congo Red staining was observed in the cortical neuropil and in leptomeningeal vessels. These data indicate that grafted leptomeningeal fibroblasts hyperexpress APP and A β which can diffuse into parenchyma and be taken up by specific rat cells.
- Published
- 1997